MedPath

Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop

Not Applicable
Recruiting
Conditions
Deep Brain Stimulation
Parkinson's Disease (PD)
Registration Number
NCT07139093
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

The investigators aim to test an interface to phase-lock transcranial alternating current stimulation (tACS) and deep brain stimulation (DBS) for future studies investigating the effects of different time-lags between DBS and tACS on the behavioural and neural level. To test if the interface works in patients with DBS, the investigators record EEG during synchronized tACS-DBS in several patients. The investigators hypothesize that they can apply tACS at the desired phase-lags relative to DBS pulses and confirm this with EEG measurements of the DBS and tACS artifact.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Provision of written informed consent by the patient
  • Age 35 - 85
  • patient groups: Parkinson's disease, essential tremor, dystonia
  • >3 months after surgery for DBS
Exclusion Criteria
  • Epilepsy or history of seizures
  • Existence of heart pacemaker or other metal implants in the body (except DBS)
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Phase-locking successduring stimulation procedure

The investigators will measure the temporal precision of the locking of the tACS to the DBS pulses should be seen. To this end, the tACS-DBS artifact and the triggers given from the interface device will be analysed offline in MATLAB.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Medical Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

University Medical Center Hamburg-Eppendorf
🇩🇪Hamburg, Germany
Monika Pötter-Nerger, MD
Contact
+49 (0) 40 7410 - 50134
m.poetter-nerger@uke.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.